Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

A genetic mutation caused severe rickets and alopecia in an Indian patient, but high-dose calcium and phosphate treatment improved their condition.

Vitamin D receptor and hairless protein are essential for hair growth.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

A new mutation in the ST14 gene broadens the understanding of ichthyosis-hypotrichosis syndrome.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Removing part of the vitamin D receptor stops vitamin D from working properly.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Maintaining the right amount of retinoic acid is crucial for healthy hair and skin.

Specific mutations in a receptor cause facial abnormalities and hair loss.

Collagen XXII is a marker for tissue junctions, aiding in structural integrity and found in muscles, heart, skin, and arthritic joints.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.